Navigation Links
Maternal Blood Test Might Spot Birth Defects More Safely
Date:11/10/2011

By Alan Mozes
HealthDay Reporter

WEDNESDAY, Nov. 9 (HealthDay News) -- In what a team of scientists says is a first, the researchers appear to have successfully screened for a rare form of fetal abnormality by means of a completely noninvasive blood test.

By performing a DNA analysis on a blood sample from a prospective mother, the team was able to accurately identify a specific chromosomal irregularity called "fetal microdeletion syndrome" in the unborn child, reported investigators at the Magee-Womens Research Institute (MWRI) at the University of Pittsburgh Medical Center.

In so doing, the researchers indicated it may one day be possible to avoid the use of much more invasive -- and thereby riskier -- standard diagnostic techniques, such as amniocentesis.

"If a fetal anomaly is suspected, mothers are usually offered an invasive screening procedure," said David Peters, head of the MWRI team and an associate professor in the department of obstetrics, gynecology and reproductive sciences.

"But there is a pretty significant, if small, level of risk to the health of the fetus associated with those tests. So there's been a strong push to try and reduce that risk," he noted.

"So I think the most compelling point," said Peters, "is that we have been able to illustrate a proof of concept. We have shown that you can identify these sorts of abnormalities without having to collect a physical sample from the baby or the placenta."

Peters and his colleagues discussed their findings in a letter published in the Nov. 10 issue of the New England Journal of Medicine.

Although this may be the first such test for this particular type of defect, maternal blood tests are also being developed for other fetal anomalies such as Down syndrome, as reported by HealthDay earlier this year. That study, conducted by Greek researchers, was published in the March 6 online edition of Nature Medicine.

According to the March of Dimes, roughly one in every 150 American babies is born with a structural or numerical chromosomal abnormality.

Such abnormalities can develop during egg or sperm cell growth, both before and after conception. Oftentimes they give rise to severe mental or physical defects, including Down syndrome and spina bifida.

Typically, chromosomal abnormalities are first identified during pregnancy by invasive diagnostic procedures.

Chorionic villus sampling is one option, involving the extraction of cellular material found in tiny finger-shaped growths located in the placenta. The procedure requires a catheter or long needle, and is usually conducted in the latter part of the first trimester.

The other option is amniocentesis, involving the extraction of a small amount of amniotic fluid surrounding the fetus for subsequent DNA analysis. The procedure is usually performed during the second trimester, and entails the use of a local anesthetic and the insertion of a needle through the mother's abdominal wall, uterus and amniotic sac.

But these invasive methods involve some risk, as fetal limb damage, fetal respiratory distress and even miscarriage can occur as a result.

To explore the potential of a less-invasive screening tool, the MWRI team focused on a couple who had already previously had a child born with physical and developmental abnormalities. In that case, the culprit was the absence (or "deletion") of specific chromosomal DNA, a condition that the child had inherited from his father.

At 21 weeks into her current pregnancy, the mother underwent traditional amniocentesis, which confirmed that her unborn child also suffered from the same rare fetal microdeletion syndrome.

In turn, at 35 weeks into the pregnancy the team drew a maternal blood sample and conducted a series of high-tech genetic sequencing tests. This time, no fetal tissue or blood was extracted.

The result: The non-invasive blood test successfully arrived at the same diagnosis as the invasive amniocentesis.

Peters acknowledged that the 35-week mark is late for prenatal screenings, but added that the time frame was appropriate for a comparative analysis of a new screening approach that is still in its infancy.

"I'm not a clinician, but I think it's fair to say that at this point we're a long way away from having something that would practically be able to replace amniocentesis," he cautioned.

Dr. De-Kun Li, a reproductive and perinatal epidemiologist in the division of research at Kaiser Permanente Northern California, in Oakland, said that while the risk associated with invasive screening is very low, an equally accurate risk-free blood test would be ideal.

"I believe the risk of spontaneous abortion or miscarriage due to an amniocentesis is 0.5 percent," he noted. "And the rate has been going down, because we are now much more technologically savvy. But of course a blood test would be noninvasive, cheaper and less risky. The question is, will the accuracy be the same? If so, then of course we'll go with the blood test. No questions asked. But that's a big 'if.'"

More information

For more on birth defects and chromosomal abnormalities, visit the March of Dimes.

SOURCES: David Peters, Ph.D., associate professor, department of obstetrics, gynecology and reproductive sciences, Magee-Womens Research Institute, University of Pittsburgh; De-Kun Li, M.D., Ph.D., M.P.H., reproductive and perinatal epidemiologist, division of research, Kaiser Permanente Northern California, Oakland, Calif.; Nov. 10, 2011, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Christy Turlington Burns to speak on energizing and broadening the Maternal Health movement
2. Harvard School of Public Health awarded $12 million grant to improve global maternal health
3. Maternal Blood Test Can Determine Sex of Fetus at 7 Weeks
4. NICHD renews maternal-fetal medicine, neonatal ties with Women & Infants
5. Society for Maternal-Fetal Medicine commends FDA on makena announcement
6. Online map of maternal health to inform world leaders
7. Citywide smoking ban contributes to significant decrease in maternal smoking, pre-term births
8. International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health
9. Closing the science-to-policy gap in maternal and child health in Africa
10. Country action is needed for maternal and child health in Africa
11. Full reproductive and sexual health rights essential for maternal health goals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Maternal Blood Test Might Spot Birth Defects More Safely
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
Breaking Medicine Technology: